Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR0516)
Drug Name
Dirithromycin
Synonyms
Dirithromycin; Dirithromycine; Dirithromycine [French]; Dirithromycinum; Dirithromycinum [Latin]; Diritromicina; Diritromicina [Spanish]; Dynabac; LY 237216; LY-237216; (9S)-9-Deoxo-11-deoxy-9,11-(imino((1R)-2-(2-methoxyethoxy)ethylidene)oxy)erythromycin; 1801D76STL; 62013-04-1; CHEBI:474014; MLS000028564; MLS001074061; SMR000058954; UNII-1801D76STL
Indication Bronchitis [ICD11: CA20] Approved [1]
Structure
3D MOL is unavailable 2D MOL
Pharmaceutical Properties Molecular Weight 835.1 Topological Polar Surface Area 196
Heavy Atom Count 58 Rotatable Bond Count 12
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 16
Cross-matching ID
PubChem CID
6473883
ChEBI ID
CHEBI:474014
CAS Number
62013-04-1
TTD Drug ID
D06ZUP
Formula
C42H78N2O14
Canonical SMILES
CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O
InChI
1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32+,33-,34+,35+,36-,37-,39+,40-,41-,42-/m1/s1
InChIKey
WLOHNSSYAXHWNR-DWIOZXRMSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Erythromycylamine DM018096 N. A. Unclear - Unclear 1 [3]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR009949 Dirithromycin Erythromycylamine Unclear - Unclear Unclear [3]
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[2]
References
1 Dirithromycin was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease. Clin Pharmacokinet. 2000 Sep;39(3):203-14.
3 Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.